33 participants
Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-24
- Start Date:
- 2026-06-23
- Completion:
- 2030-10-25
Conditions
- Anaplastic Oligodendroglioma
- Astrocytoma, IDH-Mutant, Grade 3
- Astrocytoma, IDH-Mutant, Grade 4
- Diffuse Astrocytoma
- Glioblastoma, IDH-Wildtype
- Malignant Glioma
Interventions
- PROCEDURE
- DRUG
- BIOLOGICAL
No Results Yet